180 Life Sciences Corp (ATNF)

1.76 +0.02 (+1.15%) USD  |  NASDAQ  |  May 23, 10:21
More

180 Life Sciences Revenue Estimates for Next Fiscal Year

Revenue Estimates for Next Fiscal Year Chart

View Revenue Estimates for Next Fiscal Year for ATNF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Next Fiscal Year Data

View and export this data back to 2021. Upgrade now.
Date Value
February 14, 2023 --
November 16, 2022 --
October 21, 2022 --
August 10, 2022 --
Date Value
May 09, 2022 --
February 02, 2022 --
September 15, 2021 --

Revenue Estimates for Next Fiscal Year Range, Past 5 Years

--
Minimum
Sep 15 2021
Upgrade
Maximum
Feb 14 2023
Upgrade
Average
--
Median
Sep 15 2021

Revenue Estimates for Next Fiscal Year Benchmarks

Altimmune Inc Upgrade
Seelos Therapeutics Inc Upgrade
GT Biopharma Inc Upgrade
Outlook Therapeutics Inc Upgrade
MAIA Biotechnology Inc Upgrade

Revenue Estimates for Next Fiscal Year Related Metrics

Revenue Estimates for Current Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade